Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study Journal Article


Authors: Hawryluk, E. B.; Moustafa, D.; Barry, K. K.; Bahrani, E.; Reusch, D. B.; Brahmbhatt, M.; Chen, L.; Coughlin, C. C.; Gerami, P.; Haddock, E.; Hook, K.; Humphrey, S. R.; Kao, P. C.; Kruse, L. L.; Lawley, L. P.; Mansour, D.; Marghoob, A. A.; Nguyen, J.; Phung, T. L.; Pope, E.; Raisanen, T.; Robinson, S.; Rogers, T.; Schmidt, B.; Tran, G.; Travis, K.; Wolner, Z.; London, W. B.; Eichenfield, L. F.; Huang, J.
Article Title: Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study
Abstract: Background: Pediatric melanoma presents with distinct clinical features compared to adult disease. Objective: Characterize risk factors and negative outcomes in pediatric melanoma. Methods: Multicenter retrospective study of patients under 20 years diagnosed with melanoma between January 1, 1995 and June 30, 2015 from 11 academic medical centers. Results: Melanoma was diagnosed in 317 patients, 73% of whom were diagnosed in adolescence (age ≥11). Spitzoid (31%) and superficial spreading (26%) subtypes were most common and 11% of cases arose from congenital nevi. Sentinel lymph node biopsy was performed in 68% of cases and positive in 46%. Fatality was observed in 7% of cases. Adolescent patients with melanoma were more likely to have family history of melanoma (P = .046) compared to controls. Limitations: Retrospective nature, cohort size, control selection, and potential referral bias. Conclusion: Pediatric melanoma has diverse clinical presentations. Better understanding of these cases and outcomes may facilitate improved risk stratification of pediatric melanoma. © 2024
Keywords: adolescent; cancer chemotherapy; cancer survival; child; controlled study; cancer surgery; excision; major clinical study; clinical feature; histopathology; interferon; cancer risk; cancer radiotherapy; comparative study; antineoplastic agent; lymph node dissection; sentinel lymph node biopsy; interleukin 2; melanoma; malignant lentigo; cohort analysis; oncology; retrospective study; risk factor; risk assessment; infant; multicenter study; family history; newborn; drug therapy; university hospital; xeroderma pigmentosum; voriconazole; patient referral; congenital nevus; skin surgery; superficial spreading melanoma; fatality; dermatologist; b raf kinase inhibitor; adult disease; dysplastic nevus syndrome; pediatric surgery; pediatric melanoma; immune checkpoint inhibitor; cancer prognosis; non melanoma skin cancer; breslow thickness; lymph vessel metastasis; spitzoid melanoma; human; male; female; article; acral lentiginous melanoma; pediatric dermatology; checkpoint inhibitor therapy; special situation for pharmacovigilance; oculocutaneous albinism
Journal Title: Journal of the American Academy of Dermatology
Volume: 90
Issue: 4
ISSN: 0190-9622
Publisher: Mosby Elsevier  
Date Published: 2024-04-01
Start Page: 716
End Page: 726
Language: English
DOI: 10.1016/j.jaad.2023.10.067
PUBMED: 38040338
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ashfaq A Marghoob
    534 Marghoob
  2. Tova   Rogers
    11 Rogers